Endothelial function testing as a biomarker of vascular disease - PubMed (original) (raw)

Review

Endothelial function testing as a biomarker of vascular disease

Subodh Verma et al. Circulation. 2003.

No abstract available

PubMed Disclaimer

Comment in

• Endothelial dysfunction.
  Willerson JT, Kereiakes DJ. Willerson JT, et al. Circulation. 2003 Oct 28;108(17):2060-1. doi: 10.1161/01.CIR.0000099580.72044.83. Circulation. 2003. PMID: 14581385 Review. No abstract available.

Similar articles

• Clinical utility of endothelial function testing: ready for prime time?
  Kuvin JT, Karas RH. Kuvin JT, et al. Circulation. 2003 Jul 1;107(25):3243-7. doi: 10.1161/01.CIR.0000075928.54461.33. Circulation. 2003. PMID: 12835407 Review. No abstract available.
• Is high-sensitivity C-reactive protein associated with subclinical peripheral atherosclerosis?
  Paraskevas KI, Bessias N, Papas TT, Andrikopoulos V, Mikhailidis DP. Paraskevas KI, et al. Angiology. 2009 Feb-Mar;60(1):8-11. doi: 10.1177/0003319708330707. Angiology. 2009. PMID: 19190029 No abstract available.
• Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
  Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ. Chiang KH, et al. Coron Artery Dis. 2009 Jun;20(4):267-73. doi: 10.1097/MCA.0b013e32832c459c. Coron Artery Dis. 2009. PMID: 19440065
• [Prognostic value of C-reactive protein in ischemic cardiopathy].
  Bazzino O, Natale E. Bazzino O, et al. Medicina (B Aires). 2001;61(2):239-42. Medicina (B Aires). 2001. PMID: 11374151 Spanish. No abstract available.
• New markers of inflammation and endothelial cell activation: Part I.
  Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. Szmitko PE, et al. Circulation. 2003 Oct 21;108(16):1917-23. doi: 10.1161/01.CIR.0000089190.95415.9F. Circulation. 2003. PMID: 14568885 Review. No abstract available.

Cited by

• MicroRNAs as pharmacological targets in endothelial cell function and dysfunction.
  Chamorro-Jorganes A, Araldi E, Suárez Y. Chamorro-Jorganes A, et al. Pharmacol Res. 2013 Sep;75:15-27. doi: 10.1016/j.phrs.2013.04.002. Epub 2013 Apr 18. Pharmacol Res. 2013. PMID: 23603154 Free PMC article. Review.
• Pathophysiology of Atherosclerosis.
  Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Martín C. Jebari-Benslaiman S, et al. Int J Mol Sci. 2022 Mar 20;23(6):3346. doi: 10.3390/ijms23063346. Int J Mol Sci. 2022. PMID: 35328769 Free PMC article. Review.
• Undiagnosed prediabetes status is associated with a reduced effectiveness of phosphodiesterase type 5 inhibitors in men with erectile dysfunction.
  Di Mauro M, Nicolai M, Russo GI; EAU-YAU Men’s health working party. Di Mauro M, et al. Int J Impot Res. 2020 Jul;32(4):473-474. doi: 10.1038/s41443-019-0205-0. Epub 2019 Oct 28. Int J Impot Res. 2020. PMID: 31659334 No abstract available.
• A Simple and Nonenzymatic Method to Isolate Human Corpus Cavernosum Endothelial Cells and Pericytes for the Study of Erectile Dysfunction.
  Yin GN, Ock J, Choi MJ, Song KM, Ghatak K, Minh NN, Kwon MH, Seong DH, Jin HR, Ryu JK, Suh JK. Yin GN, et al. World J Mens Health. 2020 Jan;38(1):123-131. doi: 10.5534/wjmh.180091. Epub 2019 Mar 15. World J Mens Health. 2020. PMID: 30929324 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.